Cinolazepam | |
---|---|
| |
Molecular structure via molpic | |
Molecular formula | C18H13ClFN3O2 |
Molecular mass | 357.8 g/mol |
Predicted LogP | 2 |
Solubility | 1.20e-02 g/L |
Identifiers [] | |
---|---|
IUPAC name | 3-[7-chloro-5-(2-fluorophenyl)-3-hydroxy-2-oxo-3H-1,4-benzodiazepin-1-yl]propanenitrile |
Cannonical SMILES | C1=CC=C(C(=C1)C2=NC(C(=O)N(C3=C2C=C(C=C3)Cl)CCC#N)O)F |
InChI | InChI=1S/C18H13ClFN3O2/c19-11-6-7-15-13(10-11)16(12-4-1-2-5-14(12)20)22-17(24)18(25)23(15)9-3-8-21/h1-2,4-7,10,17,24H,3,9H2 |
InChIKey | XAXMYHMKTCNRRZ-UHFFFAOYSA-N |
Cinolazepam
Cinolazepam (also known as Gerodorm, Cinolazepamum, Cinolazepam [INN], Cinolazepamum [INN-Latin], OX-373, Gerodorm (TN), Cinolazepam (INN), OX 373, BRN 5359831 or 7-Chloro-5-(o-fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propionitrile) is a substance of the benzodiazepine class.